R&D News | pharmaphorum

News

Google builds in biotech AI with Ginkgo alliance

Google Cloud and Ginkgo Bioworks have started a five-year partnership to bring artificial intelligence to biotech in areas including genomics, protein studies, and infecti

News

BlueRock clears key hurdle in Parkinson's stem cell trial

It's a case of so far, so good for BlueRock Therapeutics' first clinical trial of Parkinson's disease therapy bemdaneprocel, with no major safety issues reported after a y

News

Semaglutide scores again, this time in heart failure

The list of benefits for Novo Nordisk's semaglutide keeps getting longer.

News

Aspen taps tech firms for digital Parkinson's trial

Aspen Neuroscience is adding a digital dimension to a study of its experimental cell therapy for Parkinson's disease, with the help of tech companies Emerald Innovations a

News

AI returns voice to paralysed woman after 18 years

A stroke survivor has been given back the ability to speak for the first time in 18 years, after a breakthrough

News

US sets aside $1.4bn for COVID as new variant emerges

The Biden administration has allocated $1.4 billion to new COVID-19 vaccines and drugs, as new SARS-CoV-2 variant BA.2.86 has started spreading in the US.

Google builds in biotech AI with Ginkgo alliance

BlueRock clears key hurdle in Parkinson's stem cell trial

Semaglutide scores again, this time in heart failure

Aspen taps tech firms for digital Parkinson's trial

AI returns voice to paralysed woman after 18 years

US sets aside $1.4bn for COVID as new variant emerges

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks